Fungal phenalenones inhibit HIV-1 integrase

J Antibiot (Tokyo). 2005 Jan;58(1):65-8. doi: 10.1038/ja.2005.8.

Abstract

A phenalenone compound, atrovenetinone methyl acetal, was isolated from a culture broth of Penicillium sp. FKI-1463 as an HIV-1 integrase inhibitor, and it showed anti-HIV activity in vitro. HIV-1 integrase inhibition and anti-HIV activity of two other natural phenalenones were also studied. Among the tested compounds, funalenone inhibited HIV-1 integrase with an IC50 value of 10 microM and showed the best selectivity (anti-HIV, IC50=1.7 microM; cytotoxicity, IC50=87 microM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / chemistry
  • Antifungal Agents / pharmacology*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • HIV Integrase / drug effects*
  • Ketones / chemistry
  • Ketones / pharmacology*
  • Naphthalenes / chemistry
  • Naphthalenes / pharmacology*
  • Phenalenes / chemistry*
  • Phenalenes / pharmacology
  • Polycyclic Compounds / chemistry
  • Polycyclic Compounds / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antifungal Agents
  • Enzyme Inhibitors
  • Ketones
  • Naphthalenes
  • Phenalenes
  • Polycyclic Compounds
  • atrovenetinone
  • funalenone
  • phenalen-1-one
  • HIV Integrase